Stratification of TCE group 3 permissive HLA-DPB1 mismatches in allogeneic hematopoietic cell transplantation Diseases Group Cellular Therapy & Immunobiology Working Party (CTIWP) Type of transplant Principal investigator Esteban Arrieta-Bolaños
Survey on the current use of fecal microbiota transplantation (FMT) in patients with hematologic malignancies Diseases Group Cellular Therapy & Immunobiology Working Party (CTIWP) Type of transplant Principal investigator F. Malard
Graft-versus-Host Disease after donor-derived chimeric antigen receptor T-cell infusion post allogeneic HSCT Diseases Group Transplant Complications Working Party (TCWP) Cellular Therapy & Immunobiology Working Party (CTIWP) Type of transplant Principal investigator Guillermo Ortí
Role of HLA Evolutionary Divergence in Mismatched Unrelated Donor Hematopoietic Cell Transplantation for Malignant Hematological Disorders Diseases Group Cellular Therapy & Immunobiology Working Party (CTIWP) Principal investigator
Association between HLA evolutionary divergence and leukemia relapse after allogeneic SCT from 10/10 HLA matched related/unrelated donor Diseases Group Cellular Therapy & Immunobiology Working Party (CTIWP) Principal investigator
Graft Engineering for allogeneic hematopoietic stem cell transplantation (HSCT) and modified donor lymphocyte infusion (DLI) Diseases Group Cellular Therapy & Immunobiology Working Party (CTIWP) Type of transplant Principal investigator Moniek de Witte
Intrabone infusion of a single umbilical cord blood unit in adults with hematological disease: a Eurocord, CTIWP-EBMT Analysis Diseases Group Cellular Therapy & Immunobiology Working Party (CTIWP) Type of transplant Principal investigator Jacopo Peccatori
Monitoring virus-specific T-cell response in allogeneic hematopoietic stem cell transplant recipients Diseases Group Cellular Therapy & Immunobiology Working Party (CTIWP) Principal investigator Raffaella Greco
Influence of SARS-COV-2 pandemic on handling of allogeneic HPC grafts Diseases Group Infectious Diseases Working Party (IDWP) Cellular Therapy & Immunobiology Working Party (CTIWP) COVID-19 Principal investigator Nina Worrel
Evaluation of killer cell immunoglobulin-like receptor - HLA class I Ligand models for donor selection Group Cellular Therapy & Immunobiology Working Party (CTIWP) Type of transplant Principal investigator Johannes Schetelig
Current strategies of cell and gene therapy for solid tumors Group Cellular Therapy & Immunobiology Working Party (CTIWP) Type of transplant Principal investigator Paolo Pedrazzoli
Data collection initiative on CART Group Cellular Therapy & Immunobiology Working Party (CTIWP) Principal investigator